New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the International Journal of Molecular Sciences on November 3, 2022, titled "Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4."

Read the paper here: https://www.mdpi.com/1422-0067/23/21/13466

Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/